Amarin | AMRN - Ebitda

Hisse Senedi Fiyatı
15.23
Günlük Değişim
-0.11 -0.70%
Aylık
-2.60%
Yıllık
83.53%
Q1 Tahmin
14.88




Ebitda Değişiklik Tarih
AbbVie USD 3.52B 828M 2025-09
Alnylam Pharmaceuticals USD 145.22M 236.56M 2025-12
Amarin USD 12.54M 28.57M 2025-06
AstraZeneca USD 5.23B 272M 2025-09
BioCryst Pharmaceuticals USD 51.7M 30.14M 2025-09
DBV Technologies USD -33.48M 5.55M 2025-09
Esperion Therapeutics USD -9.93M 24.99M 2025-09
GlaxoSmithKline GBP 3.36B 179M 2025-09
Halozyme Therapeutics USD 21.9M 226.34M 2025-12
Ionis Pharmaceuticals USD -157.12M 307.36M 2025-09
Nektar Therapeutics USD -31.81M 70K 2023-09
Neurocrine Biosciences USD 218.4M 28.3M 2025-12
Novartis USD 5.88B 290M 2025-09